{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:03:28Z","timestamp":1790197408858,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,30]],"date-time":"2017-10-30T00:00:00Z","timestamp":1509321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,10,30]],"date-time":"2017-10-30T00:00:00Z","timestamp":1509321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K23DA032306"],"award-info":[{"award-number":["K23DA032306"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA030770"],"award-info":[{"award-number":["R01DA030770"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA030770-06S1"],"award-info":[{"award-number":["R01DA030770-06S1"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Justice"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s40352-017-0055-0","type":"journal-article","created":{"date-parts":[[2017,10,30]],"date-time":"2017-10-30T12:25:02Z","timestamp":1509366302000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["The continuum of hepatitis C care for criminal justice involved adults in the DAA era: a retrospective cohort study demonstrating limited treatment uptake and inconsistent linkage to community-based care"],"prefix":"10.1186","volume":"5","author":[{"given":"Karli R.","family":"Hochstatter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren J.","family":"Stockman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Holzmacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Greer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Seal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quinton A.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma K.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan P.","family":"Westergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,30]]},"reference":[{"key":"55_CR1","volume-title":"HCV guidance: Recommendations for testing, managing, and treating hepatitis C","author":"American Association for the Study of Liver Diseases and the Infectious Diseases Society of America","year":"2017","unstructured":"American Association for the Study of Liver Diseases and the Infectious Diseases Society of America (2017). HCV guidance: Recommendations for testing, managing, and treating hepatitis C. \n                    http:\/\/www.hcvguidelines.org\/sites\/default\/files\/full-guidance-pdf\/HCVGuidance_April_12_2017_b.pdf\n                    \n                  . Accessed 11 Sept 2017."},{"issue":"8","key":"55_CR2","doi-asserted-by":"publisher","first-page":"e0161241","DOI":"10.1371\/journal.pone.0161241","volume":"11","author":"K Bourgi","year":"2016","unstructured":"Bourgi, K, Brar, I, Baker-Genaw, K. (2016). Health disparities in hepatitis C screening and linkage to Care at an Integrated Health System in Southeast Michigan. PLoS One, 11(8), e0161241. doi:\n                    10.1371\/journal.pone.0161241\n                    \n                  .","journal-title":"PLoS One"},{"key":"55_CR3","volume-title":"Hepatitis C FAQs for the public","author":"Centers for Disease Control and Prevention","year":"2016","unstructured":"Centers for Disease Control and Prevention (2016a). Hepatitis C FAQs for the public. \n                    https:\/\/www.cdc.gov\/hepatitis\/hcv\/cfaq.htm\n                    \n                  . Accessed 18 July 2017."},{"key":"55_CR4","volume-title":"People born between 1945\u20131965 & hepatitis C","author":"Centers for Disease Control and Prevention","year":"2016","unstructured":"Centers for Disease Control and Prevention (2016b). People born between 1945\u20131965 & hepatitis C. \n                    https:\/\/www.cdc.gov\/hepatitis\/populations\/1945-1965.htm\n                    \n                  . Accessed 18 July 2017."},{"issue":"5","key":"55_CR5","doi-asserted-by":"publisher","first-page":"293","DOI":"10.7326\/M13-1133","volume":"160","author":"MM Denniston","year":"2014","unstructured":"Denniston, MM, Jiles, RB, Drobeniuc, J, Klevens, RM, Ward, JW, McQuillan, GM, Holmberg, SD. (2014). Chronic hepatitis C virus infection in the United States, National Health and nutrition examination survey 2003 to 2010. Annals of Internal Medicine, 160(5), 293\u2013300. doi:\n                    10.7326\/m13-1133\n                    \n                  .","journal-title":"Annals of Internal Medicine"},{"issue":"6","key":"55_CR6","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1002\/hep.25556","volume":"55","author":"MM Denniston","year":"2012","unstructured":"Denniston, MM, Klevens, RM, McQuillan, GM, Jiles, RB. (2012). Awareness of infection, knowledge, of hepatits C, and medical follow-up among individuals testing positive for hepatitis C: National Health and nutrition examination survey 2001-2008. Journal of Hepatology, 55(6), 1652\u20131661. doi:\n                    10.1002\/hep.25556\n                    \n                  .","journal-title":"Journal of Hepatology"},{"key":"55_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1023\/A:1013164814732","volume":"29","author":"PM Diamond","year":"2001","unstructured":"Diamond, PM, Wang, EW, Holzer III, CE, Thomas, C, des Anges, C. (2001). The prevalence of mental illness in prison. Administration and Policy in Mental Health, 29, 21\u201340.","journal-title":"Administration and Policy in Mental Health"},{"issue":"1","key":"55_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/wps.20306","volume":"15","author":"LB Dixon","year":"2016","unstructured":"Dixon, LB, Holoshitz, Y, Nossel, I. (2016). Treatment engagement of individuals experiencing mental illness: Review and update. World Psychiatry, 15(1), 13\u201320. doi:\n                    10.1002\/wps.20306\n                    \n                  .","journal-title":"World Psychiatry"},{"issue":"10","key":"55_CR9","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1111\/add.13877","volume":"112","author":"S Fazel","year":"2017","unstructured":"Fazel, S, Yoon, IA, Hayes, AJ. (2017). Substance use disorders in prisoners: An updated systematic review and meta-regression analysis in recently incarcerated med and women. Addiction, 112(10), 1725\u20131739. \n                    https:\/\/doi.org\/10.1111\/add.13877\n                    \n                  .","journal-title":"Addiction"},{"key":"55_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1477-7517-10-7","volume":"10","author":"M Harris","year":"2013","unstructured":"Harris, M, & Rhodes, T. (2013). Hepatitis C treatment access and uptake for people who inject drugs: A review mapping the role of social factors. Harm Reduct J, 10, 7. \n                    https:\/\/doi.org\/10.1186\/1477-7517-10-7\n                    \n                  .","journal-title":"Harm Reduct J"},{"issue":"2","key":"55_CR11","doi-asserted-by":"publisher","first-page":"84","DOI":"10.7326\/M15-0617","volume":"164","author":"T He","year":"2016","unstructured":"He, T, Li, K, Roberts, MS, Spaulding, AC, Ayer, T, Grefenstette, JJ, Chhatwal, J. (2016). Prevention of hepatitis C by screening and treatment in U.S. prisons. Annals of Internal Medicine, 164(2), 84\u201392. \n                    https:\/\/doi.org\/10.7326\/m15-0617\n                    \n                  .","journal-title":"Annals of Internal Medicine"},{"key":"55_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.drugpo.2016.12.006","volume":"42","author":"KR Hochstatter","year":"2017","unstructured":"Hochstatter, KR, Hull, SJ, Stockman, LJ, Stephens, LK, Olson-Streed, HK, Ehlenbach, WJ, \u2026 Westergaard, RP. (2017). Using database linkages to monitor the continuum of care for hepatitis C virus among syringe exchange clients: Experience from a pilot intervention. The International Journal on Drug Policy, 42, 22\u201325. doi:\n                    10.1016\/j.drugpo.2016.12.006\n                    \n                  .","journal-title":"The International Journal on Drug Policy"},{"key":"55_CR13","doi-asserted-by":"crossref","unstructured":"James D. J., & Glaze L. E.: Mental health problems of prison and jail inmates. Bureau of Justice Statistics Special Report, NCJ 213600. Washington, DC Department of Justice, 2006. \n                    https:\/\/www.bjs.gov\/content\/pub\/pdf\/mhppji.pdf","DOI":"10.1037\/e557002006-001"},{"issue":"2","key":"55_CR14","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jhep.2011.05.032","volume":"56","author":"JR Kramer","year":"2012","unstructured":"Kramer, JR, Kanwal, F, Richardson, P, Mei, M, El-Serag, HB. (2012). Gaps in the achievement of effectiveness of HCV treatment in national VA practice. Journal of Hepatology, 56(2), 320\u2013325. doi:\n                    10.1016\/j.jhep.2011.05.032\n                    \n                  .","journal-title":"Journal of Hepatology"},{"issue":"8","key":"55_CR15","doi-asserted-by":"publisher","first-page":"546","DOI":"10.7326\/M14-0602","volume":"161","author":"S Liu","year":"2014","unstructured":"Liu, S, Watcha, D, Holodniy, M, Goldhaber-Fiebert, JD. (2014). Sofosbuvir-based treatment regimens for chronic, genotype 1 hepatitis C virus infection in U.S. incarcerated populations: A cost-effectiveness analysis. Annals of Internal Medicine, 161(8), 546\u2013553. doi:\n                    10.7326\/m14-0602\n                    \n                  .","journal-title":"Annals of Internal Medicine"},{"issue":"9286","key":"55_CR16","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","volume":"358","author":"MP Manns","year":"2001","unstructured":"Manns, MP, McHutchison, JG, Gordon, SC, Rustgi, VK, Shiffman, M, Reindollar, R, \u2026 Albrecht, JK. (2001). Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial. Lancet, 358(9286), 958\u2013965.","journal-title":"Lancet"},{"issue":"1","key":"55_CR17","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3201\/eid2101.141025","volume":"21","author":"H Moorjani","year":"2015","unstructured":"Moorjani, H, Koenigsmann, C, Kim, MJ, Spaulding, AC. (2015). Prisoners treated for hepatitis C with protease inhibitor, New York, USA, 2012. Emerging Infectious Diseases, 21(1), 186\u2013188. doi:\n                    10.3201\/eid2101.141025\n                    \n                  .","journal-title":"Emerging Infectious Diseases"},{"key":"55_CR18","doi-asserted-by":"publisher","unstructured":"Moorman, AC, Gordon, SC, Rupp, LB, Spradling, PR, Teshale, EH, Lu, M, \u2026 Holmberg, SD. (2013). Baseline characteristics and mortality among people in Care for Chronic Viral Hepatitis: The chronic hepatitis cohort study. Clinical Infectious Diseases, 56(1), 40\u201350 doi:\n                    10.1093\/cid\/cis815\n                    \n                  .","DOI":"10.1093\/cid\/cis815"},{"key":"55_CR19","volume-title":"The health status of soon-to-be-released inmates: A report to congress. Chicago, National Commission on correctional health care","author":"National Commission on Correctional Health Care","year":"2002","unstructured":"National Commission on Correctional Health Care: The health status of soon-to-be-released inmates: A report to congress. Chicago, National Commission on correctional health care, 2002"},{"issue":"3","key":"55_CR20","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/QAI.0b013e31827f578a","volume":"62","author":"P Rebeiro","year":"2013","unstructured":"Rebeiro, P, Althoff, KN, Buchacz, K, Gill, J, Horberg, M, Krentz, H, \u2026 Gange, SJ. (2013). Retention among north American HIV-infected persons in clinical care, 2000-2008. Journal of Acquired Immune Deficiency Syndromes, 62(3), 356\u2013362. doi:\n                    10.1097\/QAI.0b013e31827f578a\n                    \n                  .","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"4","key":"55_CR21","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1002\/hep.25770","volume":"56","author":"JP Rice","year":"2012","unstructured":"Rice, JP, Burnett, D, Tsotsis, H, Lindstrom, MJ, Cornett, DD, Voermans, P, \u2026 Lucey, MR. (2012). Comparison of hepatitis C virus treatment between incarcerated and community patients. Journal of Hepatology, 56(4), 1252\u20131260. doi:\n                    10.1002\/hep.25770\n                    \n                  .","journal-title":"Journal of Hepatology"},{"issue":"10","key":"55_CR22","doi-asserted-by":"publisher","first-page":"762","DOI":"10.7326\/0003-4819-144-10-200605160-00010","volume":"144","author":"AC Spaulding","year":"2006","unstructured":"Spaulding, AC, Weinbaum, CM, Lau, DT, Sterling, R, Seeff, LB, Margolis, HS, Hoofnagle, JH. (2006). A framework for management of hepatitis C in prisons. Annals of Internal Medicine, 144(10), 762\u2013769.","journal-title":"Annals of Internal Medicine"},{"key":"55_CR23","doi-asserted-by":"publisher","unstructured":"Spradling, PR, Rupp, L, Moorman, AC, Lu, M, Teshale, EH, Gordon, SC, \u2026 Holmberg, SD. (2012). Hepatitis B and C virus infection among 1.2 million persons with access to care: Factors associated with testing and infection prevalence. Clin Infec Dis, 55(8), 1047\u20131055 doi:\n                    10.1093\/cid\/cis616\n                    \n                  .","DOI":"10.1093\/cid\/cis616"},{"key":"55_CR24","unstructured":"State of Wisconsin Department of Corrections. (2017a). Performance measurement series. Inmate Profile, 2016 \n                           \n                    https:\/\/doc.wi.gov\/Documents\/DataResearch\/DataAndReports\/2016InmateProfile.pdf\n                    \n                  . Accessed 18 July 2017."},{"key":"55_CR25","series-title":"Office of the Secretary research and policy unit","volume-title":"Drug Offender Prison Admission Trends (2000\u20132016)","author":"State of Wisconsin Department of Corrections","year":"2017","unstructured":"State of Wisconsin Department of Corrections (2017b). Drug Offender Prison Admission Trends (2000\u20132016). Office of the Secretary research and policy unit \n                    https:\/\/doc.wi.gov\/Documents\/DataResearch\/DataAndReports\/DrugOffenderPrisonAdmissions2000to2016.pdf\n                    \n                  . Accessed 18 July 2017."},{"issue":"4","key":"55_CR26","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1177\/0033354916662212","volume":"131","author":"LJ Stockman","year":"2016","unstructured":"Stockman, LJ, Greer, J, Holzmacher, R, Dittmann, B, Hoftiezer, SA, Alsum, LE, \u2026 Vergeront, JM. (2016). Performance of risk-based and birth-cohort strategies for identifying hepatitis C virus infection among people entering prison, Wisconsin, 2014. Public Health Reports, 131(4), 544\u2013551. doi:\n                    10.1177\/0033354916662212\n                    \n                  .","journal-title":"Public Health Reports"},{"key":"55_CR27","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/archpsyc.1996.01830060047007","volume":"53","author":"LA Teplin","year":"1996","unstructured":"Teplin, LA, Abram, KM, McClelland, GM. (1996). Prevalence of psychiatric disorders among incarcerated women, I: Pretrial jail detainees. Archives of General Psychiatry, 53, 505\u2013512.","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"55_CR28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1177\/003335491412900213","volume":"129","author":"AK Varan","year":"2014","unstructured":"Varan, AK, Mercer, DW, Stein, MS, Spaulding, AC. (2014). Hepatitis C seroprevalence among prison inmates since 2001: Still high but declining. Public Health Reports, 129(2), 187\u2013195. \n                    https:\/\/doi.org\/10.1177\/003335491412900213\n                    \n                  .","journal-title":"Public Health Reports"},{"issue":"3","key":"55_CR29","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/hep.27584","volume":"61","author":"K Viner","year":"2015","unstructured":"Viner, K, Kuncio, D, Newbern, EC, Johnson, CC. (2015). The continuum of hepatitis C testing and care. Journal of Hepatology, 61(3), 783\u2013789. doi:\n                    10.1002\/hep.27584\n                    \n                  .","journal-title":"Journal of Hepatology"},{"key":"55_CR30","volume-title":"Chapter 252: Communicable diseaes","author":"Wisconsin State Legislature","year":"2016","unstructured":"Wisconsin State Legislature (2016). Chapter 252: Communicable diseaes. \n                    http:\/\/docs.legis.wisconsin.gov\/statutes\/statutes\/252.pdf\n                    \n                  . Accessed 20 July 2017."},{"issue":"1","key":"55_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/hep.27366","volume":"61","author":"EM Yoshida","year":"2015","unstructured":"Yoshida, EM, Sulkowski, MS, Gane, EJ, Herring, RW, Ratziu, V, Ding, X, \u2026 Lawitz, E. (2015). Concordance of sustained virologic response 4, 12, and 24 weeks post-treatment with sofosbuvir-containing regimens for hepatitis C virus. Journal of Hepatology, 61(1), 41\u201345. doi:\n                    10.1002\/hep.27366\n                    \n                  .","journal-title":"Journal of Hepatology"},{"issue":"44","key":"55_CR32","doi-asserted-by":"publisher","first-page":"7846","DOI":"10.3748\/wjg.v19.i44.7846","volume":"19","author":"M Zeremski","year":"2013","unstructured":"Zeremski, M, Zibbell, JE, Martinez, AD, Kritz, S, Smith, BD, Talal, AH. (2013). Hepatitis C virus control among persons who inject drugs requires overcoming barriers to care. World Journal of Gastroenterology, 19(44), 7846\u20137851. doi:\n                    10.3748\/wjg.v19.i44.7846\n                    \n                  .","journal-title":"World Journal of Gastroenterology"}],"container-title":["Health & Justice"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40352-017-0055-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40352-017-0055-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40352-017-0055-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T18:19:27Z","timestamp":1589653167000},"score":1,"resource":{"primary":{"URL":"https:\/\/healthandjusticejournal.biomedcentral.com\/articles\/10.1186\/s40352-017-0055-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,30]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["55"],"URL":"https:\/\/doi.org\/10.1186\/s40352-017-0055-0","relation":{},"ISSN":["2194-7899"],"issn-type":[{"value":"2194-7899","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,30]]},"assertion":[{"value":"27 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research was reviewed and approved by the Tulane University Human Research Protection Program Institutional Review Board, the University of Wisconsin Health Sciences Institutional Review Board and WI DOC Research Review Committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None of the authors have any competing interests in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"10"}}